Clinical Laserthermia Systems AB (publ) (CLS-B) — Cash Flow Reinvestment Rate
Latest as of June 2022:
0.14x
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Cash Flow Reinvestment Rate of 0.14x as of June 2022, reinvesting Skr95.00K (capex Skr0.00 plus investments Skr-95.00K) from operating cash flow of Skr658.00K. See CLS-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
Skr95.00K
Capex + Investments
Operating Cash Flow
Skr658.00K
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Clinical Laserthermia Systems AB (publ) (None–None)
Year-by-year capital reinvestment analysis for Clinical Laserthermia Systems AB (publ). See Clinical Laserthermia Systems AB (publ) free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow